Trailing-twelve-month (TTM) revenue is $286.99 Million with a year-over-year growth of (9.12%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-26 | $72,166,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-26 | $76,696,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-27 | $68,797,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-26 | $69,328,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $286,987,000 |
Current P/S: $268,261,785 market capitalization ÷ $286,987,000 TTM revenue = 0.93x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:10:16.000Z. Latest revenue period ended 2026-06-26.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-26): $69.33M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:12:07.348Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-26 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-26 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-01 · USD | FY20212021-12-31 · USD | FY20222022-12-30 · USD | FY20232023-12-29 · USD | FY20242024-12-27 · USD | FY20252025-12-26 · USD |
|---|---|---|---|---|---|---|
| Consulting | $228M | $267M | N/A | N/A | N/A | N/A |
| Reimbursements | $5M | $1M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-28 · USD | FY20192019-12-27 · USD | FY20202021-01-01 · USD | FY20212021-12-31 · USD | FY20242024-12-27 · USD | FY20252025-12-26 · USD |
|---|---|---|---|---|---|---|
| Europe | N/A | N/A | N/A | N/A | $35M | $34M |
| International Primarily European Countries | $42M | $39M |
$286.99M
$286.99 Million
(9.12%)
vs. $315.79M a year ago (TTM)
+4.03%
5 Year compound annual growth rate
1 Year
(9.12%)
3 Year
(0.25%)
5 Year
+4.03%
10 Year
+0.64%
15 Year
+2.15%
20 Year
+2.44%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $305.63M | ($8.23M) | (2.62%) |
| 2024 | $313.86M | +$17.27M | +5.82% |
| 2023 | $296.59M | +$2.85M | +0.97% |
| 2022 | $293.74M | +$14.93M | +5.36% |
| 2021 | $278.81M | +$39.33M | +16.42% |
| 2020 |
TTM Growth
(9.12%)
3-Year CAGR
(0.25%)
5-Year CAGR
+4.03%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:12:07.348Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| $7M |
| $5M |
| Revenue Before Reimbursements | N/A | N/A | $290M | $291M | $307M | $301M |
|---|
| Software License Sales | $7M | $10M | N/A | N/A | N/A | N/A |
|---|
| $23M |
| N/A |
| N/A |
| North America | $222M | $222M | $208M | $254M | N/A | N/A |
|---|
| Other Australia Canada India And Uruguay | N/A | N/A | N/A | N/A | $19M | $25M |
|---|
| UNITED STATES | N/A | N/A | N/A | N/A | $259M | $246M |
|---|
| $239.48M |
| ($42.99M) |
| (15.22%) |
| 2019 | $282.47M | ($3.42M) | (1.19%) |
| 2018 | $285.89M | +$25,000 | +0.01% |
| 2017 | $285.86M | ($2.70M) | (0.94%) |
| 2016 | $288.56M | +$27.62M | +10.59% |
